Dr Xanthe Strudwick is a Research Associate within the Regenerative Medicine Laboratories of the Future Industries Institute whose research is aimed at developing novel therapeutics for wound repair, reducing scar formation and understanding the mechanisms involved in tissue regeneration. Xanthe began her research into skin biology with Professor Cowin’s laboratory at the Women’s and Children’s Health Research Institute before the lab's move to UniSA. Xanthe was awarded her PhD from UniSA for her investigation of the role of the cytoskeletal protein Flightless I in tissue regeneration. Her current research is aimed at the development of a novel antibody based therapy to reduce... Read more
About me
Dr Xanthe Strudwick is a Research Associate within the Regenerative Medicine Laboratories of the Future Industries Institute whose research is aimed at developing novel therapeutics for wound repair, reducing scar formation and understanding the mechanisms involved in tissue regeneration. Xanthe began her research into skin biology with Professor Cowin’s laboratory at the Women’s and Children’s Health Research Institute before the lab's move to UniSA. Xanthe was awarded her PhD from UniSA for her investigation of the role of the cytoskeletal protein Flightless I in tissue regeneration. Her current research is aimed at the development of a novel antibody based therapy to reduce inflammation and prevent scar formation in burn wounds. Xanthe is also working with materials scientists and physical chemists to develop novel wound dressings and investigate the use of low-temperature, atmospheric-pressure plasmas for biological and medical applications.
About me
Doctor of Philosophy University of South Australia
Bachelor of Health Science (Honours) (Medical and Pharmaceutical Biotechnology) University of South Australia
Research
Excludes commercial-in-confidence projects.
Plasma activated hydrogel therapy for combatting antimicrobial resistance in chronic wounds, NHMRC - Ideas Grants, 01/01/2021 - 31/12/2023
Research
Research outputs for the last seven years are shown below. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
| Year | Output |
|---|---|
| 2021 |
Open access
19
|
| 2021 |
18
17
38
|
| 2021 |
Open access
1
2
2
|
| 2021 |
Open access
|
| 2020 |
Open access
9
8
21
|
| 2020 |
Open access
4
4
5
|
| 2020 |
Open access
5
5
|
| 2020 |
Open access
5
5
1
|
| 2020 |
Open access
7
7
6
|
| 2020 |
Open access
7
9
1
|
| 2018 |
|
| 2018 |
Open access
|
| 2017 |
Open access
7
7
6
|
| 2016 |
Open access
24
24
2
|
| 2015 |
7
7
|
| 2015 |
Open access
25
22
9
|
| 2012 |
Open access
5
|
| 2011 |
Open access
32
33
|
| 2009 |
37
38
|
| 2009 |
33
33
|
| 2008 |
Open access
27
27
|
External engagement & recognition
| Organisation | Country |
|---|---|
| Athersys Inc | UNITED STATES |
| Athersys, Inc. | UNITED STATES |
| Australian National University | AUSTRALIA |
| John Curtin School of Medical Research | AUSTRALIA |
| Kochi Medical School | JAPAN |
| Kochi University of Technology | JAPAN |
| Lancaster University | UNITED KINGDOM |
| Meijo University | JAPAN |
| Queensland University of Technology | AUSTRALIA |
| ReGenesys | SOUTH AFRICA |
| Royal Adelaide Hospital | AUSTRALIA |
| Toyo University | JAPAN |
| University of Adelaide | AUSTRALIA |
| University of California | UNITED STATES |
| University of Freiburg | GERMANY |
| University of Liverpool | UNITED KINGDOM |
| University of Lubeck | GERMANY |
| University of New South Wales | AUSTRALIA |
| University of South Australia | AUSTRALIA |
| Women and Children's Health Research Institute | CANADA |
| Women's & Children's Health Research Institute Inc | AUSTRALIA |
| Women's and Children's Health Network | AUSTRALIA |
Teaching & student supervision
Supervisions from 2010 shown
| Thesis title | Student status |
|---|---|
| Alterations in bone -related gene expression pattern induced by growth and sex hormones in growing and ageing rats | Current |
